Published

Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The Transmitter
Date: 2023-01-01
Source: OpenAlex
DOI: 10.53053/etcr6498
PubMed: Unavailable

Authors

Peter Hess

Watch author

Derived topics and classifications

psilocybin Pharmacology Receptor Pharmacology Clinical Trial Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data2023-01-01

Related papers

Psychedelics for Psychiatric Disorders: More Research NeededPsychiatric News · 2020-04-13 Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10 Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric DisordersJournal of Pharma Insights and Research. · 2025-10-05 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01